These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9202623)

  • 1. A simplified schedule to integrate the hepatitis B vaccine into an expanded program of immunization in endemic countries.
    Lee CY; Lee PI; Huang LM; Chen JM; Chang MH
    J Pediatr; 1997 Jun; 130(6):981-6. PubMed ID: 9202623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
    Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen content Haemophilus influenzae type b vaccine in Filipino children.
    Gatchalian SR; Ramakrishnan G; Bock HL; Lefevre I; Jacquet JM
    Hum Vaccin; 2010 Aug; 6(8):664-72. PubMed ID: 20657177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age.
    Aristegui J; Muñiz J; Pérez Legorburu A; Imaz M; Arrate JP; Suárez MD; Goiri MD
    Vaccine; 1995 Aug; 13(11):973-7. PubMed ID: 8525690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quadrivalent vaccine against diphtheria, tetanus, B. pertussis and hepatitis B: experience in Spain].
    González López A; Arístegui Fernández J; Díez-Delgado J; Dal-Ré Saavedra R
    An Esp Pediatr; 1998 Feb; 48(2):132-7. PubMed ID: 9577019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN; Phuong NT; Toan NT; Thang HV
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of two diphtheria-tetanus-whole cell pertussis-hepatitis B vaccines in infants: a comparative trial.
    Kulkarni PS; Sapru A; Bavdekar A; Naik SS; Patwardhan M; Barde P; Pandit AN
    Hum Vaccin; 2011 Sep; 7(9):941-4. PubMed ID: 21921700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher anti-hepatitis B response with combined DTPw-HBV vaccine compared with separate administration in healthy infants at 3, 4 and 5 months of age in Slovakia.
    Prikazsky V; Bock HL
    Int J Clin Pract; 2001 Apr; 55(3):156-61. PubMed ID: 11351767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine.
    Stehr K; Cherry JD; Heininger U; Schmitt-Grohé S; uberall M; Laussucq S; Eckhardt T; Meyer M; Engelhardt R; Christenson P
    Pediatrics; 1998 Jan; 101(1 Pt 1):1-11. PubMed ID: 9417143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B.
    Grosheide PM; del Canho R; Voogd M; Heijtink RA; Schalm SW
    Vaccine; 1994 Sep; 12(12):1059-63. PubMed ID: 7998413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
    Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
    Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the reactogenicity and immunogenic potency of combined vaccine "Bubo-Kok" in the immunization of children against diphtheria, tetanus, pertussis and viral hepatitis B].
    Fel'dblium IV; Nikolaeva AM; Kuz'ianin AV; Borisova VN; Mel'nikov VA; Chuprinina RP; Perelygina OV; Shalunova NV; Semenova VD; Griaznova DV; Pushkareva EV; Uvitskiĭ AIu; Alekseeva IA; Konopleva OA; Budanov MV; Iakovleva IM
    Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):58-62. PubMed ID: 15554315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to diphtheria, tetanus and pertussis in infants before and after immunization with DTP (Triple Antigen) vaccine.
    Stewart TA; Nolan TM; Hogg G; McEwen J
    J Paediatr Child Health; 1996 Oct; 32(5):378-81. PubMed ID: 8933394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
    Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.
    Martins Rde M; Camacho LA; Marcovistz R; Noronha TG; Maia Mde L; dos Santos EM; Barbosa GG; Silva AM; Souza PC; Lemos MC; Homma A
    Mem Inst Oswaldo Cruz; 2008 Nov; 103(7):711-8. PubMed ID: 19057823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.